Good news for plant and animal breeders and molecular biologists in general with the new oKtopure™ from LGC, the fully-automatic extraction of DNA becomes almost as easy as child's play. This DNA extraction robot combines high sample throughput numbers with high-quality standardized DNA purification and thus relieves highly-qualified personnel of the need to carry out routine activities. Part of the solution is a handling system based on electric axes, motors and controllers from Festo.
Proportional valve technology in process automation offers a great a deal of flexibility and produces high-quality control results. A complete system supplied by Festo and installed in Boehringer Ingelheim's new technical centre demonstrates the performance that modern pneumatics can deliver. The project was developed in close communication between the Festo team and automation experts from the pharmaceutical company, allowing it to move forward quickly.
Today’s biotech and pharmaceutical production facilities must drive faster times to market and greater profitability for new products by boosting production yields and accelerating commercialization and scaling of capacity.
AstraZeneca is a global, science-led biopharmaceutical business. They are one of a handful of companies to span the entire life cycle of a medicine – from research and development to manufacturing and supply – as well as the global commercialization of primary care and specialty care medicines. Operating in more than 100 countries, AstraZeneca employs around 57,500 people worldwide. The company has manufacturing operations in 17 countries, and their innovative medicines are used by millions of patients worldwide.
As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount.